Company intelligence / Profile preview

Frenelle Pharma

Plymouth, Minnesota, United Statesfrenellepharma.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Frenelle’s Faros™ platform has demonstrated safety and efficacy in a Phase 2 study for back pain and shows promise in substance use disorder treatment. The company collaborates with Mayo Clinic on opioid addiction therapies and has launched three subsidiaries targeting human therapeutics, addiction medicine, and animal health. Clinical results indicate strong potential to improve safety profiles of long-term injectable medications by reducing risks associated with intravenous misuse.[1][3][4]

Therapeutic areas: OtherPsychiatryNeurology
Modalities: Long-acting injectables (LAIs) using biodegradable microspheresdrug delivery technology
Industry: Biotech

Drug pipeline

1 asset

SX600

Phase 2

Indications: Lumbar radicular pain, Sciatica

Partnerships

Mayo Clinic (collaboration on substance use disorder treatments)[1][4]ProMed Pharma (manufacturing partnership via SpineThera)[5]

Beyond the preview

Go deeper on Frenelle Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Frenelle Pharma.

Explore the full profile